Hester Biosciences Limited (HESTERBIO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hester Biosciences Limited (HESTERBIO) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs174.78 Million ≈ $1.89 Million USD) by net assets (Rs3.51 Billion ≈ $37.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HESTERBIO net asset quality index to measure how much of total assets are equity-financed.
Hester Biosciences Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Hester Biosciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Hester Biosciences Limited cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Hester Biosciences Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hester Biosciences Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Stellar V Capital Corp. Unit
NASDAQ:SVCCU
|
0.000x |
|
Ucore Rare Metals Inc
V:UCU
|
-0.080x |
|
LightWave Acquisition Corp.
NASDAQ:LWAC
|
-0.001x |
|
Bitcoin Infrastructure Acquisition Corp Ltd. Class A Ordinary Shares
NASDAQ:BIXI
|
14.443x |
|
Jih Lin Technology Co Ltd
TW:5285
|
0.010x |
|
Youlchon Chem
KO:008730
|
0.029x |
|
Amazing Microelectronic
TWO:6411
|
0.030x |
|
Síminn hf
IC:SIMINN
|
0.082x |
Annual Cash Flow Conversion Efficiency for Hester Biosciences Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Hester Biosciences Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see HESTERBIO market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs3.27 Billion ≈ $35.33 Million |
Rs645.11 Million ≈ $6.98 Million |
0.197x | +24.27% |
| 2024-03-31 | Rs3.03 Billion ≈ $32.75 Million |
Rs481.34 Million ≈ $5.21 Million |
0.159x | +96.92% |
| 2023-03-31 | Rs2.92 Billion ≈ $31.62 Million |
Rs235.96 Million ≈ $2.55 Million |
0.081x | +145.00% |
| 2022-03-31 | Rs2.67 Billion ≈ $28.92 Million |
Rs88.08 Million ≈ $952.55K |
0.033x | -86.61% |
| 2021-03-31 | Rs2.36 Billion ≈ $25.52 Million |
Rs580.53 Million ≈ $6.28 Million |
0.246x | +32.67% |
| 2020-03-31 | Rs2.06 Billion ≈ $22.33 Million |
Rs382.92 Million ≈ $4.14 Million |
0.185x | -30.32% |
| 2019-03-31 | Rs1.81 Billion ≈ $19.59 Million |
Rs482.10 Million ≈ $5.21 Million |
0.266x | +1.48% |
| 2018-03-31 | Rs1.45 Billion ≈ $15.68 Million |
Rs380.24 Million ≈ $4.11 Million |
0.262x | -6.41% |
| 2017-03-31 | Rs1.24 Billion ≈ $13.43 Million |
Rs347.98 Million ≈ $3.76 Million |
0.280x | +51.04% |
| 2016-03-31 | Rs1.05 Billion ≈ $11.34 Million |
Rs194.44 Million ≈ $2.10 Million |
0.186x | -34.69% |
| 2015-03-31 | Rs838.58 Million ≈ $9.07 Million |
Rs238.21 Million ≈ $2.58 Million |
0.284x | +129.46% |
| 2014-03-31 | Rs762.88 Million ≈ $8.25 Million |
Rs94.44 Million ≈ $1.02 Million |
0.124x | -26.51% |
| 2013-03-31 | Rs684.95 Million ≈ $7.41 Million |
Rs115.37 Million ≈ $1.25 Million |
0.168x | -27.37% |
| 2012-03-31 | Rs610.60 Million ≈ $6.60 Million |
Rs141.61 Million ≈ $1.53 Million |
0.232x | -14.56% |
| 2011-03-31 | Rs479.85 Million ≈ $5.19 Million |
Rs130.26 Million ≈ $1.41 Million |
0.271x | -18.64% |
| 2010-03-31 | Rs408.64 Million ≈ $4.42 Million |
Rs136.33 Million ≈ $1.47 Million |
0.334x | +57.34% |
| 2009-03-31 | Rs366.47 Million ≈ $3.96 Million |
Rs77.71 Million ≈ $840.36K |
0.212x | -27.97% |
| 2008-03-31 | Rs334.69 Million ≈ $3.62 Million |
Rs98.53 Million ≈ $1.07 Million |
0.294x | -30.04% |
| 2007-03-31 | Rs279.47 Million ≈ $3.02 Million |
Rs117.60 Million ≈ $1.27 Million |
0.421x | +225.91% |
| 2006-03-31 | Rs136.48 Million ≈ $1.48 Million |
Rs17.62 Million ≈ $190.56K |
0.129x | -- |
About Hester Biosciences Limited
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through the Poultry Healthcare and Animal Healthcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl… Read more